These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6730768)

  • 21. Endometrial carcinoma in Stein-Leventhal syndrome treated with hydroxyprogesterone caproate.
    Eddy WA
    Am J Obstet Gynecol; 1978 Jul; 131(5):581-2. PubMed ID: 677198
    [No Abstract]   [Full Text] [Related]  

  • 22. The treatment of advanced endometrial cancer with hydroxyprogesterone caproate.
    Reifenstein EC
    Gynecol Oncol; 1974 Aug; 2(2-3):377-414. PubMed ID: 4616884
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of progestational agents in treatment of endometrial carcinoma.
    Podratz KC; O'Brien PC; Malkasian GD; Decker DG; Jefferies JA; Edmonson JH
    Obstet Gynecol; 1985 Jul; 66(1):106-10. PubMed ID: 4011061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of different progestogens on lipoproteins during postmenopausal replacement therapy.
    Hirvonen E; Mälkönen M; Manninen V
    N Engl J Med; 1981 Mar; 304(10):560-3. PubMed ID: 7453723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wnt-7a is upregulated by norethisterone in human endometrial epithelial cells: a possible mechanism by which progestogens reduce the risk of estrogen-induced endometrial neoplasia.
    Oehler MK; MacKenzie IZ; Wallwiener D; Bicknell R; Rees MC
    Cancer Lett; 2002 Dec; 186(1):75-81. PubMed ID: 12183078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-acting progestins--promise and prospects.
    Popul Rep K; 1983 May; 11(2):K17-55. PubMed ID: 6222930
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cytological check-up on the effectiveness of the hormonal treatment of endometriosis].
    Kopecný J; Kopecná V
    Cesk Gynekol; 1973; 38(1):38-9. PubMed ID: 4729366
    [No Abstract]   [Full Text] [Related]  

  • 28. [Excretion of follicle-stimulating and steroid hormones in patients with uterine cancer during treatment with 17-hydroxyprogesterone caproate].
    Sharoukhova KS; Vershinina GN; Murav'eva NI; Smirnova KD; Goncharova MG
    Akush Ginekol (Mosk); 1970 Oct; 46(10):9-13. PubMed ID: 5519750
    [No Abstract]   [Full Text] [Related]  

  • 29. Progestogen regulation of tissue plasminogen activator in a human melanoma cell line.
    Kjaeldgaard A; Ahlesteen I; Larsson B; Astedt B
    Thromb Res; 1988 Jan; 49(2):287-97. PubMed ID: 3129818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of benign prostatic hypertrophy with progestogens including gestonorone caproate].
    Nagel R; Hargenda B
    Hinyokika Kiyo; 1970 Sep; 16(9):423-8. PubMed ID: 4097356
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of progestogens on vaginal cytology.
    Heber KR
    Acta Cytol; 1975; 19(2):103-9. PubMed ID: 47675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvant hormone therapy of primary endometrial carcinoma with oxyprogesterone caproate.
    Bokhman JV; Chepick OF; Volkova AT; Vishnevsky AS
    Gynecol Oncol; 1981 Jun; 11(3):371-8. PubMed ID: 6788657
    [No Abstract]   [Full Text] [Related]  

  • 33. 17-alpha-hydroxyprogesterone caproate treatment of gynecologic cancer.
    Hreshchyshyn MM; Graham RM
    Am J Obstet Gynecol; 1969 Jul; 104(6):916-8. PubMed ID: 5792777
    [No Abstract]   [Full Text] [Related]  

  • 34. [The effect of hydroxyprogesterone caproate and its combination with tamoxifen on steroid hormone receptors in the tumor and on the basic parameters of reproductive homeostasis in patients with cancer of the corpus uteri].
    Vishnevskiĭ AS; Bokhman IaV; Tsyrlina EV; Bobrov IuF; Shtofmakher IA
    Vopr Onkol; 1989; 35(9):1063-7. PubMed ID: 2815695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women.
    Nugent AG; Leung KC; Sullivan D; Reutens AT; Ho KK
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):690-8. PubMed ID: 14974909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levo-norgestrel-nova-T and precancerous lesions of the endometrium.
    Scarselli G; Tantini C; Colafranceschi M; Taddei GL; Bargelli G; Venturini N; Branconi F
    Eur J Gynaecol Oncol; 1988; 9(4):284-6. PubMed ID: 3391204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of adjuvant hormonotherapy on the results of the radiation treatment of patients with cancer of the corpus uteri].
    Bokhman IaV; Stoliarova IV; Gastev AIu
    Vopr Onkol; 1987; 33(4):49-52. PubMed ID: 3296435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Emergency ambulatory treatment of dysfunctional metrorrhagia in adolescents].
    Morini A; Mossa B; Roscetti C; Florio V
    Minerva Ginecol; 1989 Nov; 41(11):547-50. PubMed ID: 2533669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hormonal transformation characteristics of endometrial adenoacanthoma in the process of progestin treatment].
    Shenderëva TS; Shvedova LA
    Vopr Onkol; 1981; 27(10):52-6. PubMed ID: 7303557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral contraception: a review.
    Edgren RA
    Int J Fertil; 1991; 36 Suppl 3():16-25. PubMed ID: 1687400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.